Literature DB >> 15103277

[Ehlers Danlos type IV syndrome presenting with simultaneous dissection of both internal carotid and both vertebral arteries].

K Mondon1, B de Toffol, G Georgesco, J-F Cassarini, M-C Machet, J-P Cottier, B Arbeille, A Autret.   

Abstract

INTRODUCTION: Dissection of cervical arteries is a frequent cause of stroke in young subjects. CASE REPORT: We report the case of a 34-year-old patient who experienced simultaneous dissection of both internal carotid arteries and both vertebral arteries leading to repeated motor deficit of the right half-body associated with persistent otalgia. Search for an etiology led to the diagnosis of Ehlers-Danlos syndrome type IV.
CONCLUSION: Search for the cause of cervical artery dissection must consider connective tIssue disease, particularly vascular forms of Ehler-Danlos syndrome. Diagnostic, therapeutic as well as prognostic aspects are discussed.

Entities:  

Mesh:

Year:  2004        PMID: 15103277     DOI: 10.1016/s0035-3787(04)70934-0

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  4 in total

1.  Type IV Ehlers-Danlos syndrome presenting as recurrent, bilateral carotid dissections.

Authors:  Richard James Booth Ellis; Maqsud Salehin; Rui Zhou; Mohammad Somauroo
Journal:  BMJ Case Rep       Date:  2012-12-12

Review 2.  Neurovascular manifestations of connective-tissue diseases: A review.

Authors:  Sarasa T Kim; Waleed Brinjikji; Giuseppe Lanzino; David F Kallmes
Journal:  Interv Neuroradiol       Date:  2016-08-10       Impact factor: 1.610

3.  Hereditary connective tissue diseases in young adult stroke: a comprehensive synthesis.

Authors:  Olivier M Vanakker; Dimitri Hemelsoet; Anne De Paepe
Journal:  Stroke Res Treat       Date:  2011-01-20

4.  Innominate truncal and arch blowout with left hemiparesis and right hemothorax followed by delayed cheese-wire perforation of innominate graft.

Authors:  Pankaj Kaul; Rodolfo Paniagua
Journal:  J Cardiothorac Surg       Date:  2013-04-23       Impact factor: 1.637

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.